These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8281714)

  • 1. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
    Arimura Y; Minoshima S; Kamiya Y; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Sasaki T; Suzuki K
    Clin Nephrol; 1993 Nov; 40(5):256-64. PubMed ID: 8281714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
    Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
    Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical investigation of anti-myeloperoxidase antibodies in patients with glomerulonephritis with crescent formation].
    Arimura Y; Nohmi K; Tanaka U; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1087-93. PubMed ID: 1962827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
    Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
    Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice.
    Ishida-Okawara A; Ito-Ihara T; Muso E; Ono T; Saiga K; Nemoto K; Suzuki K
    Nephrol Dial Transplant; 2004 Jul; 19(7):1708-15. PubMed ID: 15150352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Yorioka N; Taniguchi Y; Amimoto D; Ogata S; Sakikubo E; Yamakido M; Naito T; Shimamoto F
    Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
    Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
    Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
    Huugen D; Xiao H; van Esch A; Falk RJ; Peutz-Kootstra CJ; Buurman WA; Tervaert JW; Jennette JC; Heeringa P
    Am J Pathol; 2005 Jul; 167(1):47-58. PubMed ID: 15972951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of anti-myeloperoxidase antibodies-associated idiopathic crescentic glomerulonephritis with pulmonary hemorrhage].
    Arimura Y; Minoshima S; Kamiya Y; Motohashi S; Nakabayashi K; Kitamoto K; Nagasawa T; Suzuki K
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):1011-6. PubMed ID: 1663175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Hasegawa M; Nishii C; Ohashi A; Tomita M; Nakai S; Murakami K; Nabeshima K; Fujita Y; Ishii J; Hiki Y; Sugiyama S
    Nephron Clin Pract; 2009; 113(3):c222-33. PubMed ID: 19690440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis.
    Fujii A; Tomizawa K; Arimura Y; Nagasawa T; Ohashi YY; Hiyama T; Mizuno S; Suzuki K
    Clin Nephrol; 2000 Apr; 53(4):242-52. PubMed ID: 10809410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.
    Nagao T; Kusunoki R; Iwamura C; Kobayashi S; Yumura W; Kameoka Y; Nakayama T; Suzuki K
    Microbiol Immunol; 2013 Sep; 57(9):640-50. PubMed ID: 23829825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
    Ohtani H; Wakui H; Komatsuda A; Chyzh KA; Hatakeyama T; Masai R; Okuyama S; Togashi M; Sawada K
    Ren Fail; 2007; 29(2):183-7. PubMed ID: 17365934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.
    Heeringa P; Brouwer E; Klok PA; Huitema MG; van den Born J; Weening JJ; Kallenberg CG
    Am J Pathol; 1996 Nov; 149(5):1695-706. PubMed ID: 8909258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
    Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.